A comparison of two regimens of streptomycin plus PAS in the retreatment of pulmonary tuberculosis.
D000351:Africa, Eastern; D000636:Aminosalicylic Acids / Q000008:administration & dosage* / Q000009:adverse effects; D000995:Antitubercular Agents / Q000008:administration & dosage; D004342:Drug Hypersensitivity; D004357:Drug Synergism; D006801:Humans; D012877:Skin Manifestations; D013183:Sputum / Q000382:microbiology; D013272:Stomach Diseases / Q000139:chemically induced; D013307:Streptomycin / Q000008:administration & dosage* / Q000009:adverse effects; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014717:Vertigo / Q000139:chemically induced
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D013307:Streptomycin